Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of TRC4186 in stable chronic heart failure with type 2 diabetes or elevated HbA1c
NL-OMON33519Phase 2Not yet recruiting
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of TRC4186 in chronic heart failure (CHF) and type 2 diabetes mellitus (T2DM), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Physical dimension of Minnesota Living with Heart Failure Questionnaire and Oxygen uptake efficiency slope. Planned start Aug 2009; status: not yet recruiting.
02
Drugs
TRC4186
03
Conditions
chronic heart failure (CHF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON33519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33519.